That's ok, I'm still ahead with DDD and I expect to do a lot better. I'm not fretting, there's plenty of other stocks to occupy my time with.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025